Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
IGC Pharma, Inc. (IGC) had Receiveable Turnover of 8.51 for the most recently reported fiscal year, ending 2023-03-31.
| Income Statement Financials | |
$0.91M |
|
$-11.51M |
|
$0.47M |
|
$0.44M |
|
$12.48M |
|
$-11.57M |
|
$0.07M |
|
$-11.51M |
|
$-11.51M |
|
$-11.51M |
|
$-11.51M |
|
$-11.51M |
|
$-11.51M |
|
$-11.57M |
|
$-10.91M |
|
52.58M |
|
52.58M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$6.47M |
|
$8.21M |
|
$10.71M |
|
$17.18M |
|
$1.90M |
|
$0.14M |
|
$0.37M |
|
$2.27M |
|
$14.91M |
|
$13.74M |
|
$14.91M |
|
53.08M |
|
| Cash Flow Statement Financials | |
$-7.05M |
|
$-0.23M |
|
$0.10M |
|
$10.46M |
|
$3.20M |
|
$-7.26M |
|
$2.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.41 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
48.52% |
|
-1270.14% |
|
-1270.14% |
|
-1198.02% |
|
-1263.01% |
|
-1263.01% |
|
$-6.82M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.18 |
|
|
Receiveable Turnover |
8.51 |
42.87 |
|
-77.16% |
|
-83.73% |
|
-66.98% |
|
-76.44% |
|
$0.28 |
|
$-0.13 |
|
$-0.13 |
|